TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Transcervical Foley Balloon Plus Vaginal Misoprostol Versus Vaginal Misoprostol Alone For Cervical Ripening In Nulliparous Obese Women: A Randomized, Comparative Effectiveness Trial
Brief Summary: Obese pregnant women (BMI ≥ 30 kg/m2) are more likely than their normal-weight counterparts to require induction of labor because of increased rates of obstetric complications including pregnancy related hypertensive disorders, diabetes, and prolonged gestations. Several studies have shown that obese women experience increased labor duration and oxytocin needs when compared to normal-weight women. This in turn results in increased rates for unplanned cesarean delivery (CD) as a result of failed induction of labor (IOL), arrest disorders and non-reassuring fetal heart rate tracing, that is dose-dependent with increasing class of obesity. The investigators hypothesize that obese pregnant women and unfavorable cervix (Bishop score ≤ 6), IOL ≥ 24 weeks gestation using the Foley balloon plus vaginal misoprostol will result in reduced cesarean delivery rates when compared to vaginal misoprostol alone.


Options:
A: Arm Label: Combined approach: Foley Balloon + Vaginal Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley Balloon + Vaginal Misoprostol | Arm Label: Single approach: Vaginal Misoprostol only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vaginal Misoprostol | Intervention Type: DRUG; Name: Vaginal Misoprostol; Assigned to Arm(s): Single approach: Vaginal Misoprostol only | Intervention Type: DEVICE; Name: Foley Balloon + Vaginal Misoprostol; Assigned to Arm(s): Combined approach: Foley Balloon + Vaginal Misoprostol
B: Arm Label: Foley Bulb plus Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley bulb | Arm Label: Misoprostol; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): Foley Bulb plus Misoprostol
C: Arm Label: misoprostol group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol | Arm Label: misoprostol and foley bulb group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol, Device: Foley bulb | Intervention Type: DEVICE; Name: misoprostol; Assigned to Arm(s): misoprostol and foley bulb group, misoprostol group | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): misoprostol and foley bulb group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: ARD (Atad Ripener Device) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: AID (Atad double balloon Instillation Device) | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Device: folly catheter | Intervention Type: DEVICE; Name: ARD (Atad Ripener Device); Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: AID (Atad double balloon Instillation Device); Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: folly catheter; Assigned to Arm(s): 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of Random Telephone Calls to Measure Immunosuppressive Therapy Adherence in Patients With Renal Transplants
Brief Summary: Nonadherence to medication is a major obstacle to successful treatment of renal transplant patients. This study has two primary aims. The first is to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription. Participants will be randomly assigned to either group CBT or to standard care. The second aim is to pilot a novel strategy of adherence measurement - unannounced telephone pill counts, which has been shown to be a valid and reliable means to measure medication adherence in other patient populations. Participants will be recruited from waiting area of the kidney transplant clinic at SUNY Downstate Medical Center in Brooklyn, NY. Three unannounced telephone pill counts will be conducted prior to start of the intervention in order to establish baseline adherence and three pill counts will be conducted post-intervention. Tacrolimus trough concentration levels will also be collected as an additional biological measure of adherence.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: mHealth Intervention | Intervention Type: OTHER; Name: mHealth Intervention; Assigned to Arm(s): mHealth Intervention
B: Arm Label: Group CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral adherence promotion program | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Care | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral adherence promotion program; Assigned to Arm(s): Group CBT | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care
C: Arm Label: ICT based monitoring group; Type: EXPERIMENTAL; Interventions: Device: Feedback using ICT based monitoring system | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Feedback using ICT based monitoring system; Assigned to Arm(s): ICT based monitoring group
D: Arm Label: Telemetric Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Telemetric Intervention | Arm Label: Standard of Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemetric Intervention; Assigned to Arm(s): Telemetric Intervention Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trauma-sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma
Brief Summary: In this study, we are evaluating the effectiveness of a yoga intervention to treat posttraumatic stress disorder (PTSD), its associated symptoms of chronic pain and insomnia, and biological and physiological responses to trauma and PTSD in women Veterans who experienced military sexual trauma (MST). If effective, this yoga intervention could reduce PTSD symptoms and chronic pain, improve sleep quality, and decrease the body's automatic "fight or flight" stress response and the damage this stress response causes in the body, including heart disease and diabetes. This intervention could improve these women Veterans' quality of life and social functioning, for example, going to work and having satisfying relationships with family and friends. This study may support an innovative, complementary and alternative PTSD treatment for women Veterans who experienced MST. This new, evidence-based PTSD treatment could supplement current PTSD treatments. Clinical guidelines for this yoga intervention could be implemented nationally in the VA health care system.


Options:
A: Arm Label: Brief Cognitive Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Cognitive Therapy | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Therapy; Assigned to Arm(s): Brief Cognitive Intervention
B: Arm Label: Motivational Interviewing (MI); Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing (MI) | Intervention Type: BEHAVIORAL; Name: Motivational interviewing (MI); Assigned to Arm(s): Motivational Interviewing (MI)
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: RHANI Wives Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RHANI WIves | Intervention Type: BEHAVIORAL; Name: RHANI WIves; Assigned to Arm(s): RHANI Wives Intervention
D: Arm Label: Trauma Center Trauma-Sensitive Yoga (TCTSY); Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Center Trauma Sensitive Yoga Intervention (TCTSY) | Arm Label: Cognitive Processing Therapy (CPT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Center Trauma Sensitive Yoga Intervention (TCTSY); Assigned to Arm(s): Trauma Center Trauma-Sensitive Yoga (TCTSY) | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy (CPT)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) - Induced Pancreatitis Using Aggressive Lactated Ringer's Infusion and/or Rectal Indomethacin
Brief Summary: Post-ERCP pancreatitis is a well-known and sometimes life-threatening complication of ERCP. Both LR and rectal indomethacin have shown benefit in preventing post-ERCP pancreatitis. Despite this, no study to date has evaluated both of these measures for preventing post-ERCP pancreatitis. It is our hope to evaluate the combination of these two modalities for preventing post-ERCP pancreatitis compared with either modality alone.


Options:
A: Arm Label: loop-tip arm; Type: EXPERIMENTAL; Interventions: Device: Loop-tip wire (Cook Medical) for the cannulation of the CBD | Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Device: Cannulotome CT-25mm Cook Medical | Intervention Type: DEVICE; Name: Loop-tip wire (Cook Medical) for the cannulation of the CBD; Assigned to Arm(s): loop-tip arm | Intervention Type: DEVICE; Name: Cannulotome CT-25mm Cook Medical; Assigned to Arm(s): Control arm
B: Arm Label: 0.035 guidewire; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional 0.035 guidewire | Arm Label: Olympus Visiglide 0.025 guidewire; Type: ACTIVE_COMPARATOR; Interventions: Device: Olympus Visiglide 0.025 guidewire | Intervention Type: DEVICE; Name: Conventional 0.035 guidewire; Assigned to Arm(s): 0.035 guidewire | Intervention Type: DEVICE; Name: Olympus Visiglide 0.025 guidewire; Assigned to Arm(s): Olympus Visiglide 0.025 guidewire
C: Intervention Type: PROCEDURE; Name: Double guide wire technique; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Standard bile duct cannulation; Assigned to Arm(s): N/A
D: Arm Label: A (NS+Placebo); Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal Saline, Drug: Placebo | Arm Label: B (NS+IND); Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin, Drug: Normal Saline | Arm Label: C (LR+Placebo); Type: ACTIVE_COMPARATOR; Interventions: Drug: Lactated Ringer's Solution, Drug: Placebo | Arm Label: D (LR+IND); Type: EXPERIMENTAL; Interventions: Drug: Indomethacin, Drug: Lactated Ringer's Solution | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): B (NS+IND), D (LR+IND) | Intervention Type: DRUG; Name: Lactated Ringer's Solution; Assigned to Arm(s): C (LR+Placebo), D (LR+IND) | Intervention Type: DRUG; Name: Normal Saline; Assigned to Arm(s): A (NS+Placebo), B (NS+IND) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A (NS+Placebo), C (LR+Placebo)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Follicular Flushing Improve the Outcome in Monofollicular IVF Therapy?
Brief Summary: Follicular aspiration as well as follicular flushing are standardized techniques and have been practiced in polyfollicular IVF (in vitro fertilization) therapy for years. Monofollicular IVF therapy is a standard technique as well. IVF can be done in natural cycles or with a minimal stimulation with clomifen citrate to achieve a monofollicular response. Our study aims to compare follicular aspiration and follicular flushing in monofollicular stimulation. First the investigators want to answer the question whether flushing is beneficial for the oocyte yield. In case of a positive result the investigators want to establish a recommendation about the optimal number of flushings taking into account the duration of the procedure and the pain during manipulation.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: SL1(Cook® Single Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)" | Arm Label: DL1 (Cook® EchoTip® Double Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)" | Intervention Type: DEVICE; Name: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)"; Assigned to Arm(s): SL1(Cook® Single Lumen) | Intervention Type: DEVICE; Name: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)"; Assigned to Arm(s): DL1 (Cook® EchoTip® Double Lumen)
C: Arm Label: follicular flushing group; Type: EXPERIMENTAL; Interventions: Other: follicular flushing | Arm Label: aspiration group; Type: ACTIVE_COMPARATOR; Interventions: Other: no follicular flushing | Intervention Type: OTHER; Name: follicular flushing; Assigned to Arm(s): follicular flushing group | Intervention Type: OTHER; Name: no follicular flushing; Assigned to Arm(s): aspiration group
D: Arm Label: Follicular flushing; Type: ACTIVE_COMPARATOR; Interventions: Other: Aspiration without flushing follicles with culture media, Other: Follicular Flushing | Intervention Type: OTHER; Name: Aspiration without flushing follicles with culture media; Assigned to Arm(s): Follicular flushing | Intervention Type: OTHER; Name: Follicular Flushing; Assigned to Arm(s): Follicular flushing

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Cardiovascular Disease With the Vegetarian Diet: the CARDIVEG Study
Brief Summary: The study is a randomized, open, cross-over trial designed to test whether a vegetarian diet would benefit the cardiovascular risk profile of the participants, compared with a Mediterranean diet.


Options:
A: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Other: Brazilian heart-prevent meal | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: Heart prevent control meal weekly | Arm Label: Group 3; Type: EXPERIMENTAL; Interventions: Other: Heart prevent control Meal monthly | Intervention Type: OTHER; Name: Brazilian heart-prevent meal; Assigned to Arm(s): Group 1 | Intervention Type: OTHER; Name: Heart prevent control meal weekly; Assigned to Arm(s): Group 2 | Intervention Type: OTHER; Name: Heart prevent control Meal monthly; Assigned to Arm(s): Group 3
B: Arm Label: New Nordic Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary intervention | Arm Label: Average Danish Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary intervention | Intervention Type: BEHAVIORAL; Name: Dietary intervention; Assigned to Arm(s): Average Danish Diet, New Nordic Diet
C: Arm Label: Stanol ester; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Stanol ester spread | Arm Label: Placebo spread; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo spread | Arm Label: Mediterranean diet group; Type: OTHER; Interventions: Dietary Supplement: Mediterranean Diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Stanol ester spread; Assigned to Arm(s): Stanol ester | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo spread; Assigned to Arm(s): Placebo spread | Intervention Type: DIETARY_SUPPLEMENT; Name: Mediterranean Diet; Assigned to Arm(s): Mediterranean diet group
D: Arm Label: Veg Group; Type: EXPERIMENTAL; Interventions: Other: Vegetarian diet, Other: Mediterranean diet | Arm Label: Med group; Type: ACTIVE_COMPARATOR; Interventions: Other: Vegetarian diet, Other: Mediterranean diet | Intervention Type: OTHER; Name: Vegetarian diet; Assigned to Arm(s): Med group, Veg Group | Intervention Type: OTHER; Name: Mediterranean diet; Assigned to Arm(s): Med group, Veg Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis
Brief Summary: Background and Aims: Liver transplantation is the only curative treatment modality for decompensated cirrhosis and is limited by donor organ availability and financial resources; thus many patients die while awaiting liver transplant. Granulocyte colony stimulating factor (GCSF) therapy can mobilize bone marrow stem cells for tissue regeneration, and has been shown to benefit patients with liver disease. The investigators evaluated the efficacy of GCSF therapy in decompensated cirrhosis in an open labelled randomized control trial.

Patients and Methods: Consecutive patients with decompensated cirrhosis of mixed etiologies were randomized to receive either a 5-day course of GCSF (5 μg/kg/d) plus standard medical therapy for 6 months (Group-A); or standard medical therapy alone for 6 months (Group-B). At the end of 6 months their survival were compared.


Options:
A: Arm Label: Granulocyte colony-stimulating factor; Type: EXPERIMENTAL; Interventions: Drug: Granulocyte colony-stimulating factor, Drug: standard treatment | Arm Label: standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: standard treatment | Intervention Type: DRUG; Name: Granulocyte colony-stimulating factor; Assigned to Arm(s): Granulocyte colony-stimulating factor | Intervention Type: DRUG; Name: standard treatment; Assigned to Arm(s): Granulocyte colony-stimulating factor, standard treatment
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: G-CSF | Arm Label: G-CSF; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: G-CSF; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): G-CSF
C: Arm Label: standard medical therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: standard medical therapy | Arm Label: G-CSF; Type: ACTIVE_COMPARATOR; Interventions: Drug: standard medical therapy, Drug: G-CSF | Arm Label: G-CSF plus growth hormone; Type: ACTIVE_COMPARATOR; Interventions: Drug: standard medical therapy, Drug: G-CSF, Drug: Growth Hormone | Intervention Type: DRUG; Name: standard medical therapy; Assigned to Arm(s): G-CSF, G-CSF plus growth hormone, standard medical therapy | Intervention Type: DRUG; Name: G-CSF; Assigned to Arm(s): G-CSF, G-CSF plus growth hormone | Intervention Type: DRUG; Name: Growth Hormone; Assigned to Arm(s): G-CSF plus growth hormone
D: Arm Label: GCSF+SMT; Type: EXPERIMENTAL; Interventions: Drug: Granulocyte Colony Stimulating Factor | Arm Label: SMT; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Granulocyte Colony Stimulating Factor; Assigned to Arm(s): GCSF+SMT

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye
Brief Summary: This is a two-year longitudinal study investigating the optical and structural effects of increased compression factor of orthokeratology lens on eyes and the corresponding effect on change in choroidal thickness and therefore myopic control.


Options:
A: Arm Label: Single-vision glasses; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Orthokeratology with normal compression factor; Type: SHAM_COMPARATOR; Interventions: Device: Orthokeratology | Arm Label: Orthokeratology with increased compression factor; Type: ACTIVE_COMPARATOR; Interventions: Device: Orthokeratology | Intervention Type: DEVICE; Name: Orthokeratology; Assigned to Arm(s): Orthokeratology with increased compression factor, Orthokeratology with normal compression factor
B: Arm Label: Test lens C; Type: EXPERIMENTAL; Interventions: Device: 1 Day Acuvue Moist | Arm Label: Test lens A; Type: ACTIVE_COMPARATOR; Interventions: Device: 1 Day Acuvue Moist | Intervention Type: DEVICE; Name: 1 Day Acuvue Moist; Assigned to Arm(s): Test lens A, Test lens C
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Outdoor activity; Type: EXPERIMENTAL; Interventions: Behavioral: Outdoor activity | Intervention Type: BEHAVIORAL; Name: Outdoor activity; Assigned to Arm(s): Outdoor activity
D: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: increasing time spent outdoors | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: increasing time spent outdoors; Assigned to Arm(s): intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Designing a Food Benefit Program to Optimize Diet Quality for Obesity Prevention
Brief Summary: This highly innovative experimental trial is designed to examine the independent and joint effects of prohibiting the use of SNAP-like benefits to purchase foods high in discretionary calories and offering an incentive to encourage the purchase of more healthful foods.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
B: Arm Label: Vegetable exposure; Type: EXPERIMENTAL; Interventions: Other: Vegetable exposure | Arm Label: VIPP-Feeding Infants; Type: EXPERIMENTAL; Interventions: Behavioral: VIPP-Feeding Infants | Arm Label: Exposure + VIPP-FI; Type: EXPERIMENTAL; Interventions: Other: Vegetable exposure, Behavioral: VIPP-Feeding Infants | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Vegetable exposure; Assigned to Arm(s): Exposure + VIPP-FI, Vegetable exposure | Intervention Type: BEHAVIORAL; Name: VIPP-Feeding Infants; Assigned to Arm(s): Exposure + VIPP-FI, VIPP-Feeding Infants | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Parenting Insight; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Parenting Insights | Arm Label: Child Safety Insights; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Child Safety Insights; Assigned to Arm(s): Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Parenting Insights; Assigned to Arm(s): Parenting Insight
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Rewards; Type: EXPERIMENTAL; Interventions: Behavioral: F&V Bonus | Arm Label: Restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Restriction | Arm Label: Rewards plus restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Bonus & Restriction | Intervention Type: BEHAVIORAL; Name: F&V Bonus; Assigned to Arm(s): Rewards | Intervention Type: BEHAVIORAL; Name: Restriction; Assigned to Arm(s): Restrictions | Intervention Type: BEHAVIORAL; Name: Bonus & Restriction; Assigned to Arm(s): Rewards plus restrictions

Answer: D